SynteractHCR Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:SynteractHCR Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013531
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SynteractHCR Inc (SynteractHCR), a subsidiary of Amulet Capital Partners LP is a contract research organization that offers clinical trials support services. The organization provides phase I – IV clinical development services, clinical services, vendor management, study document development, project management, risk mitigation and management, and clinical trial management system. It offers medical and regulatory affair services; clinical monitoring and site management; clinical data management, training, feasibility studies, patient diaries, treatment kit assignment and re-supply; medical writing and biostatistical services. SynteractHCR caters to therapeutic areas of cardiovascular, oncology, neurology, pain, psychiatry, endocrinology, immunotherapy, ophthalmology, infectious disease and respiratory. The organization serves pharmaceutical, biotechnology and medical device companies in different phases of clinical development. It operates in the US, Austria, Belgium, the Czech Republic, Denmark, Germany, France, Italy, Poland, Ukraine, Spain, Russia, Sweden and the UK. SynteractHCR is headquartered in Carlsbad, California, the US.

SynteractHCR Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SynteractHCR Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Amulet Capital Partners Acquires SynteractHCR 10
Partnerships 11
SynteractHCR and GOG Foundation Enter into Agreement 11
Acquisition 12
Synteract Completes Acquisition Of Harrison Clinical Research To Form SynteractHCR 12
SynteractHCR Inc – Key Competitors 14
SynteractHCR Inc – Key Employees 15
SynteractHCR Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Corporate Communications 18
Oct 25, 2017: CRO Industry Veteran John Potthoff Joins SynteractHCR Board of Directors 18
Aug 10, 2017: SynteractHCR Announces New Chief Medical Officer Dr. Frank Santoro 19
Jul 17, 2017: SynteractHCR Names Steve Powell as Chief Executive Officer 20
Apr 19, 2017: SynteractHCR Adds Another Three Senior Executives To Management Team With Both U.S. and International Clinical Trials Operations Experience 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
SynteractHCR Inc, Pharmaceuticals & Healthcare, Key Facts 2
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SynteractHCR Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SynteractHCR Inc, Deals By Therapy Area, 2011 to YTD 2017 8
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Amulet Capital Partners Acquires SynteractHCR 10
SynteractHCR and GOG Foundation Enter into Agreement 11
Synteract Completes Acquisition Of Harrison Clinical Research To Form SynteractHCR 12
SynteractHCR Inc, Key Competitors 14
SynteractHCR Inc, Key Employees 15
SynteractHCR Inc, Other Locations 16
SynteractHCR Inc, Subsidiaries 16

★海外企業調査レポート[SynteractHCR Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Quantum Fuel Systems LLC:電力:M&Aディール及び事業提携情報
    Summary Quantum Fuel Systems LLC (Quantum) is a provider of natural gas storage systems, integration and vehicle system technologies. The company produces advanced and lightweight compressed natural gas (CNG) storage tanks and fully integrated natural gas storage systems and supplies these tanks to …
  • Sequella Inc-医療機器分野:企業M&A・提携分析
    Summary Sequella Inc (Sequella) is a clinical-stage pharmaceutical company that develops and commercializes small molecule and natural product-based therapeutics for the treatment of infectious diseases. The company’s product pipeline include SQ109, Sutezolid, SQ641 and SQ609; and a novel rapid anti …
  • Aplus Financial Co Ltd.:企業の戦略・SWOT・財務情報
    Aplus Financial Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aplus Financial Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Maxim Integrated Products Inc (MXIM):企業の財務・戦略的SWOT分析
    Maxim Integrated Products Inc (MXIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Gleason Research Associates Inc:企業の戦略的SWOT分析
    Gleason Research Associates Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Cadence Design Systems, Inc.:企業の戦略・SWOT・財務情報
    Cadence Design Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cadence Design Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Jaya Tiasa Holdings Berhad (JTIASA):企業の財務・戦略的SWOT分析
    Jaya Tiasa Holdings Berhad (JTIASA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Zealand Pharma AS (ZEAL):製薬・医療:M&Aディール及び事業提携情報
    Summary Zealand Pharma AS (Zealand) is a biotechnology company that discovers, designs and develops peptide based medicines that targets specialty diseases. The company’s marketed products comprise Lyxumia and Suliqua for the treatment of Type 2 diabetes and others for the treatment of obesity and f …
  • Entasis Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Entasis Therapeutics Inc (Entasis) is a drug development company that discovers and develops anti-infective therapies for drug-resistant bacterial infections. The company’s pipeline products include ETX2514, ETX0282, ETX0914 and Zoliflodacin. Its ETX2514 is a potent inhibitor of class A, C, …
  • Parker Hannifin Corp (PH):石油・ガス:M&Aディール及び事業提携情報
    Summary Parker Hannifin Corp (Parker) is a manufacturer of motion and control technologies and systems. The company offers critical motion and control solutions, including fluid power systems, electromechanical controls and related components. Its products find use in various industries and applicat …
  • NeoGenomics Inc (NEO):企業の財務・戦略的SWOT分析
    Summary NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immuno …
  • Swan Life Ltd.:企業の戦略・SWOT・財務情報
    Swan Life Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swan Life Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • PT Pertamina (Persero):石油・ガス:M&Aディール及び事業提携情報
    Summary PT Pertamina (Persero) (Pertamina) is a state-owned integrated energy company. It has operations across the energy value chain from upstream to downstream. Its upstream operations include exploration, development and production of oil and natural gas. The company also provides upstream techn …
  • Spineway SAS (ALSPW):企業の財務・戦略的SWOT分析
    Summary Spineway SAS (Spineway) is a medical device company that manufactures, designs, and commercializes surgical implants and instruments. The company offers products such as thoraco-lumbar, cervical, mini invasive products and other bio materials. Its thoraco-lumbar products include mont blanc d …
  • Veritone, Inc. (VERI):企業の財務・戦略的SWOT分析
    Veritone, Inc. (VERI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Targa Resources Partners LP (NGLS PR A):企業の財務・戦略的SWOT分析
    Targa Resources Partners LP (NGLS PR A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Baltimore Gas and Electric Company:発電所・企業SWOT分析
    Baltimore Gas and Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • Clark Public Utilities:企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • The People’s Insurance Company (Group) of China Limited:企業の戦略・SWOT・財務情報
    The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report Summary The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Expedia Inc:戦略・SWOT・企業財務分析
    Expedia Inc - Strategy, SWOT and Corporate Finance Report Summary Expedia Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆